Win Advisors Inc. purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,482 shares of the conglomerate’s stock, valued at approximately $1,255,000.
Other large investors also recently added to or reduced their stakes in the company. Enterprise Financial Services Corp boosted its position in shares of Danaher by 1.4% in the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after buying an additional 46 shares during the period. Kennebec Savings Bank grew its holdings in shares of Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after buying an additional 46 shares in the last quarter. Revolve Wealth Partners LLC grew its holdings in shares of Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after buying an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC grew its holdings in shares of Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after buying an additional 48 shares in the last quarter. Finally, Norway Savings Bank grew its holdings in shares of Danaher by 0.7% during the fourth quarter. Norway Savings Bank now owns 7,063 shares of the conglomerate’s stock valued at $1,617,000 after buying an additional 49 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Danaher
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 10.80% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Get Our Latest Report on Danaher
Danaher Stock Performance
Shares of NYSE DHR opened at $166.46 on Tuesday. The business’s 50-day moving average price is $189.62 and its two-hundred day moving average price is $211.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a one year low of $165.25 and a one year high of $242.80. The company has a market capitalization of $117.82 billion, a P/E ratio of 32.20, a price-to-earnings-growth ratio of 2.29 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the firm earned $1.88 earnings per share. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.0%. Danaher’s payout ratio is currently 30.95%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
